06:45 AM EDT, 09/12/2024 (MT Newswires) -- Moderna ( MRNA ) said Thursday it is reducing its R&D expense by about $1.1 billion starting in 2027 in light of "recent commercial challenges."

The company now expects 2025 revenue of $2.5 billion to $3.5 billion. Analysts polled by Capital IQ expect $3.95.

Moderna ( MRNA ) shares fell 8.3% in recent premarket activity.

Price: 72.90, Change: -6.61, Percent Change: -8.31